Company intelligence / Profile preview

Renovo Neural

Cleveland, Ohio, United States

Ownership: Private
Development stage: Other

Overview

Renovo Neural provides preclinical services to screen small molecules for remyelination potential in MS and operates a commercial high-speed 3D electron microscopy service, speeding research and discovery. The company has exclusive rights to a candidate MS compound but has not advanced it past preclinical research as of the latest information[1].

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Clients in pharmaceutical industry (names not disclosed)

Beyond the preview

Go deeper on Renovo Neural.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renovo Neural.

Explore the full profile